Member Info for hants

For everyones convenience, here's a link to listen
https://talkradio.co.uk/radioplayer/live/talkradio.html

Maybe around 70p. I hope so anyway, as that will turn me to blue!

CEO goes on national TV and gives excellent interview, bringing product to the attention of the masses.

Share price goes down.

Seems legit.

Absolutely excellent interview. Delivered all the key points concisely, with enough detail but without going OTT.

Not wanting to spam, but - the guy whos on now really needs to sort his wallpaper out before live streaming his house on the news.

You legends, I didn't know that! Thanks!

I don't have sky news, or even a tv licence for that matter. If somebody would kindly take some notes for those of us in the dark ages, that would be much appreciated!

Why worry unless you're day trading? Nothing much will happen until theres another RNS. There's a good product in the pipeline.

Good things come to those who wait.

Themuir, just seen your previous post on NCYT. As per my post on here couple of days ago, I closed the last of my position there and put the funds into Avacta. Sold the remainder at 479. I felt the same way as you on that one. I looked yesterday and it was about 435, so I got out just in time. Although it appears it's recovered a bit today, it's still not back at the same level. I'll be surprised if it nudges 500 again.

We all need to ride the waves with Avacta. I've a low average so probably easy for me to say, but I believe those who are brave and sit tight will be rewarded!

I've just made a small top up. Be rude not to at these prices!

Lot of sellers at the moment - losing their nerve by the looks of things. One persons loss is anothers gain. Great opportunity to buy in at the moment.

The man himself!
May I also add my thanks for the work you've done and then published for the benefit of others.

My apologies, you are quite right.

A lot more than three times Zebbo! Your maths is a bit out.

But look at where NCYT were a few weeks ago, I believe that's where we are now. Ahead of the rise.

NCYT have a lab test which is approved and they are taking orders, hence the huge spike end of last week.

AVCT, still in development - albeit EXTREMELY promising.

If that website did the weather it would say "tomorrow is will be snowing all day, 30 degrees and sunny."

That's quite a big question Geordie and I could give many reasons but the three main ones would be these.

1. Getting a treatment or vaccine approved for use is complex. Some treatments can cause harm or side effects. A test like this, however, just needs to be accurate. Indications are that Avacta can already accurately detect Covid, as I'm sure you'll know if you've been researching.

2. Market size. How many people will need treatment? Well lots sadly, but compared to the number of people who will be tested, not many. Same principle with vaccine. That would probably only go out to the vulnerable, at least initially. The market for testing is basically the entire planet, several times a week maybe. It's not hard to imagine employers, airlines etc testing people on arrival with a quick to use test like this.

Also something to think about:- The lab tests are fine (to an extent) in the first world. But what about the third world?

3. Partnership with Cytiva. That's massive. Why would Cytiva choose Avacta if the product was a non starter? Also, it's fine having a good product but you need to produce and districute it on a huge scale. That's an undertaking in itself.

Today I closed the remainder of my position in NCYT. I feel that one has run most of it's course now, and even with future RNS - I believe the expectation of profit is so high that it's already priced in. There will surely be more companies with approved lab based tests soon, so the competition is only going to increase. It's still going to be a big pie, but it's going to be cut into more slices. (I dare not write this on the NCYT board though as I will be attacked by an angry mob with pitchforks.)

I have taken that money and used it to double my holding in Avacta, they have a niche here which needs filling ASAP. All the indications are that Avacta will be successful, especially with Cytiva on board. The demand for lab based tests will, IMO, be significantly dented if, or should I say when, Avacta bring this product to market - hence moving more funds accross to here.

This is the place to be and I'm happy to be in here early. My average is now a bit higher due to the buy today, however I'm not overly concerned. In a few weeks time, this will be so high that it will be irrelevant. All IMO. Do your own research etc.

Slightly off the topic of this board;
Also holding some other Covid related stocks: SNG (very nicely advanced product), small holding in TILS (error I think, need to sell that one), ODG (due to Gov backing I think this could go far), GDR (another small holding, for potential with and also beyond Covid19), ORPH (Flu-V seems interesting), TEK (for Covid and non-Covid products).

Avacta is my largest holding and the one which I am the most hopeful about.

I'm in and straight into the blue. That being said, I think I've bought in on a high and we might see this pull back before it goes further, but I'm okay with that. Been doing some speed research this morning and this looks very good indeed.

Can't buy in through IG markets at present.

Must be magic, as his username suggests?

Rich - I've just seen kewjosh's posts over at TILS (which I have a very small holding in, as a punt only!), I see now he's just here to de-ramp. Pathetic.